Cardiovascular disease in Africa: epidemiological profile and challenges.
Ashley K Keates, Ana O Mocumbi, Mpiko Ntsekhe...
https://pubmed.ncbi.nlm.nih.gov/28230175Actively Recruiting
Age: 18Years +
All Genders
Healthy Volunteers
ID05661318
Aswan Heart Centre - Ballana Heart Study
Led by Magdi Yacoub Heart Foundation · Updated on 2024-05-29
5000
Participants Needed
1
Research Sites
213 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to understand cardiovascular disease (CVD) in the Ballana population in Egypt by studying its incidence, prevalence, progression, and risk factors including genetic background. The study will create a valuable foundation for cardiovascular research and assist in designing future studies and informing health policies. It focuses on defining the cardiovascular characteristics, genetic information, and other biological markers for CVD in this population over a long period. The study will randomly select 1,200 households in Ballana to participate. After enrolling, participants will have their cardiovascular profiles assessed, including clinical, laboratory, and genetic data collection. High-risk participants will be followed annually, while others will be evaluated every three years. This follow-up will continue for up to 30 years to monitor changes and cardiovascular events. Participants will be involved in regular assessments of their cardiovascular health, including risk evaluations and data collection on genetics and other health indicators. Researchers will continuously monitor cardiovascular risk over the 30-year period. The study includes consent procedures and requires participants to have a valid National ID. The long-term follow-up will provide detailed information on cardiovascular risk and progression in this community.
CONDITIONS
Brief Title
AHC Ballana Heart Study
Who Can Participate
Age: 18Years +
All Genders
Healthy Volunteers
Eligibility Criteria
You may qualify if you...
- Residents of Ballana from the 1,200 randomly selected households
- Participants must have a valid National ID card
- Written informed consent
- Age 18 years or older
You will not qualify if you...
- Residents who are younger than 18 years
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Diagnostic Evaluation
Duration - Initial assessment at enrollment
Participants undergo cardiovascular risk assessment including clinical, laboratory, and genetic data collection after providing informed consent.
1 visit (in-person)
Long-term Monitoring
Duration - Up to 30 years
Participants are followed up for changes in their cardiovascular profile and cardiovascular events over time.
Annual visits for high risk participants; every 3 years for others
Trial Site Locations
Total: 1 location
1
Aswan Heart Centre - Magdi Yacoub Heart Foundation
Aswān, Egypt
Actively Recruiting
Loading map...
Research Team
Y
Yasmine Aguib, PhD
A
Ahmed Elguindy, MD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here